|
KMID : 1084220150220050313
|
|
Journal of Rheumatic Diseases
2015 Volume.22 No. 5 p.313 ~ p.316
|
|
|
A Case Report of SAPHO Syndrome Treated with Oral Alendronate
|
|
Shim Hyun-Ik
Park Won
Kim Yeo-Ju
Jung Kyong-Hee
Baek Ji-Hyeon
Lim Mie-Jin
Joo Ko-Woon
Kwon Seong-Ryul
|
|
|
Abstract
|
|
|
|
SAPHO syndrome, characterized by synovitis, acne, pustulosis, hyperostosis, and osteitis is rare compared to other spondyloarthropathies. It is also difficult to diagnose, and treatment methods have not yet been fully identified. Approximately 72% of patients are diagnosed with at least one other disease before a final diagnosis of SAPHO syndrome. In addition, SAPHO syndrome is subject to a delayed diagnosis period of 4.5 to 9.1 years. Medications such as non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and tumor necrosis factor inhibitors are used in treatment of SAPHO syndrome. Bisphosphonate is also used for refractory SAPHO syndrome; however, most reports on this relate to intravenous injection of medication. The authors experienced and subsequently reported on a case involving a patient with SAPHO syndrome accompanied by fracture and infection of the left second finger who was treated with the oral biphosphonate, alendronate.
|
|
|
KEYWORD
|
|
|
Acquired hyperostosis syndrome, Therapeutics, Alendronate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|